Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2026-02-04 00:00:00 ET · period of report 2026-02-02 · accession 0000905148-26-000496 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-04 | 2026-02-02 | RIGL | Furey Raymond J. | EVP, GC, CCO, Corp Sec | F - Tax | $36.01 | -3,968 | 35.9K | -10% | -$142.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-02 | F | D | 3,968 | $36.01 | 35,862 | D | — | — | (F1) Includes 1,000 shares acquired under the Issuer's stock purchase plan. |